FDA Modernization Act 2.0
Legislation passed by the United States Congress at the end of 2022 that removes the mandatory requirement for animal testing in new drug approvals, permitting the use of human-cell-based alternative methods.
Timeline (last 90 days)
The 2022 FDA Modernization Act 2.0 was passed by the U.S. Congress and eliminated the mandatory requirement for animal testing in new drug approvals.
The FDA Modernization Act 2.0 does not ban animal testing, but rather allows pharmaceutical companies, with FDA recognition, to use human-cell-based alternative methods (such as organoids, organ-on-a-chip, and computer models) to meet safety assessment requirements.
All Facts (2)
The FDA Modernization Act 2.0 does not ban animal testing, but rather allows pharmaceutical companies, with FDA recognition, to use human-cell-based alternative methods (such as organoids, organ-on-a-chip, and computer models) to meet safety assessment requirements.
50%UnverifiedThe 2022 FDA Modernization Act 2.0 was passed by the U.S. Congress and eliminated the mandatory requirement for animal testing in new drug approvals.
50%